Davidson Sean M, Takov Kaloyan, Yellon Derek M
The Hatter Cardiovascular Institute, 67 Chenies Mews, WC1E 6HX, London, UK.
Cardiovasc Drugs Ther. 2017 Feb;31(1):77-86. doi: 10.1007/s10557-016-6698-6.
Most, if not all, cells of the cardiovascular system secrete small, lipid bilayer vesicles called exosomes. Despite technical challenges in their purification and analysis, exosomes from various sources have been shown to be powerfully cardioprotective. Indeed, it is possible that much of the so-called "paracrine" benefit in cardiovascular function obtained by stem cell therapy can be replicated by the injection of exosomes produced by stem cells. However, exosomes purified from plasma appear to be just as capable of activating cardioprotective pathways. We discuss the potential roles of endogenous exosomes in the cardiovascular system, how this is perturbed in cardiovascular disease, and evaluate their potential as therapeutic agents to protect the heart.
心血管系统的大多数(即便不是全部)细胞都会分泌一种名为外泌体的小型脂质双层囊泡。尽管外泌体的纯化和分析存在技术挑战,但已证明来自各种来源的外泌体具有强大的心脏保护作用。事实上,干细胞疗法在心血管功能方面所获得的许多所谓“旁分泌”益处,有可能通过注射干细胞产生的外泌体来复制。然而,从血浆中纯化的外泌体似乎同样能够激活心脏保护途径。我们讨论了内源性外泌体在心血管系统中的潜在作用、其在心血管疾病中是如何受到干扰的,并评估了它们作为保护心脏的治疗药物的潜力。